leoworm
2021-09-16
Test
US IPO yesterday review：IPO boom comeback<blockquote>美国IPO昨日回顾：IPO热潮卷土重来</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
6
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":885284410,"tweetId":"885284410","gmtCreate":1631798247030,"gmtModify":1631891164452,"author":{"id":3554294506154172,"idStr":"3554294506154172","authorId":3554294506154172,"authorIdStr":"3554294506154172","name":"leoworm","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Test</p></body></html>","htmlText":"<html><head></head><body><p>Test</p></body></html>","text":"Test","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/885284410","repostId":1140671590,"repostType":4,"repost":{"id":"1140671590","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631797610,"share":"https://www.laohu8.com/m/news/1140671590?lang=zh_CN&edition=full","pubTime":"2021-09-16 21:06","market":"us","language":"en","title":"US IPO yesterday review：IPO boom comeback<blockquote>美国IPO昨日回顾：IPO热潮卷土重来</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1140671590","media":"Tiger Newspress","summary":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion i","content":"<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week.</p><p><blockquote>在短暂的假期周经历了一波发行之后，本周有10起IPO计划筹集超过30亿美元的资金。</blockquote></p><p> There were 8 IPOs shining on Wednesday.</p><p><blockquote>周三有8只IPO大放异彩。</blockquote></p><p> <b>Thoughtworks</b></p><p><blockquote><b>Thoughtworks</b></blockquote></p><p> Shares of Thoughtworks Inc jumped nearly 40% in their Nasdaq debut on Wednesday, valuing the company at nearly $9 billion, after the software consultancy firm priced its initial public offering well above range.</p><p><blockquote>Thoughtworks Inc周三在纳斯达克首次公开募股的定价远高于区间，该公司股价上涨近40%，估值接近90亿美元。</blockquote></p><p> The company’s stock opened at $26, compared with its initial public offering price of $21. This was above its targeted price range of $18 to $20.</p><p><blockquote>该公司股票开盘价为26美元，而其首次公开募股价格为21美元。这高于其18至20美元的目标价格范围。</blockquote></p><p> Backed by Germany’s Siemens AG, Thoughtworks sold 16.4 million shares in the IPO, raising about $344 million. Other investors, including funds advised by Apax Partners, sold about 20.4 million shares.</p><p><blockquote>在德国西门子公司的支持下，Thoughtworks在IPO中出售了1640万股股票，筹集了约3.44亿美元。包括Apax Partners咨询的基金在内的其他投资者出售了约2040万股。</blockquote></p><p> The company, which helps firms digitize their operations, counts Canadian wireless carrier Telus Corp, German luxury carmaker Daimler AG, U.S. supermarket chain Kroger Co and payments company PayPal Holdings Inc as customers.</p><p><blockquote>该公司帮助企业实现运营数字化，其客户包括加拿大无线运营商Telus Corp、德国豪华汽车制造商Daimler AG、美国连锁超市Kroger Co和支付公司PayPal控股公司。</blockquote></p><p> <b>On Holding AG</b></p><p><blockquote><b>安控股股份公司</b></blockquote></p><p> Shares of Roger Federer-backed On Holding AG jumped nearly 46% in their debut on the New York Stock Exchange on Wednesday.</p><p><blockquote>周三，罗杰·费德勒(Roger Federer)支持的On Holding AG股价在纽约证券交易所首次亮相时上涨了近46%。</blockquote></p><p> The company sold 31.1 million shares in its initial public offering (IPO) priced at $24, well above its $20 to $22 target price range, raising $746.4 million. Its stock opened at $35.40.</p><p><blockquote>该公司在首次公开募股（IPO）中以24美元的价格出售了3110万股，远高于其20至22美元的目标价区间，筹集了7.464亿美元。其股票开盘价为35.40美元。</blockquote></p><p> On was founded in 2010 by running enthusiasts Olivier Bernhard, David Allemann and Caspar Coppetti, with Federer investing an undisclosed sum in the company in 2019.</p><p><blockquote>On由跑步爱好者Olivier Bernhard、David Allemann和Caspar Coppetti于2010年创立，费德勒于2019年向该公司投资了一笔未公开的金额。</blockquote></p><p> <b>Dutch Bros</b></p><p><blockquote><b>荷兰兄弟</b></blockquote></p><p> Shares of Dutch Bros Inc, which is backed by private equity firm TSG, rose over 59% in their stock market debut on Wednesday.</p><p><blockquote>由私募股权公司TSG支持的Dutch Bros Inc的股价周三在股市首次亮相时上涨了59%以上。</blockquote></p><p> Shares opened at $32.5, compared to the initial public offering price of $23 per share.</p><p><blockquote>股价开盘价为32.5美元，而首次公开募股价格为每股23美元。</blockquote></p><p> Dutch Bros was founded in 1992 by brothers Dane and Travis Boersma, third-generation dairy farmers who were forced to leave the business due to industry-wide disruption. They started experimenting with coffee beans and began selling espresso from a pushcart by the railroad tracks in Grants Pass, Oregon, which is still the company’s headquarters.</p><p><blockquote>Dutch Bros由Dane Boersma和Travis Boersma兄弟于1992年创立，他们是第三代奶农，由于全行业的混乱而被迫离开该公司。他们开始尝试咖啡豆，并开始在俄勒冈州格兰茨帕斯的铁轨旁用手推车出售浓缩咖啡，那里仍然是公司的总部。</blockquote></p><p> The coffee chain sold 21.1 million shares in its IPO on Tuesday, raising about $484 million. The IPO was priced above Dutch Bros’ earlier targeted price range of $18 per share to $20 per share.</p><p><blockquote>这家咖啡连锁店周二在IPO中出售了2110万股股票，筹集了约4.84亿美元。此次IPO定价高于荷兰兄弟此前每股18美元至20美元的目标价格区间。</blockquote></p><p> <b>Definitive Healthcare</b></p><p><blockquote><b>权威医疗保健</b></blockquote></p><p> Shares of Definitive Healthcare rose over 60% in their stock market debut on Wednesday.</p><p><blockquote>Definitive Healthcare的股价在周三首次上市时上涨了60%以上。</blockquote></p><p> Definitive Healthcare Corp Class A Shares Open At $37.25 In Nasdaq Debut Versus Ipo Price Of $27.00/Share.</p><p><blockquote>Definitive Healthcare Corp A类股票在纳斯达克首次亮相时开盘价为37.25美元，而Ipo价格为每股27.00美元。</blockquote></p><p> The company had said overnight that it raised $420.0 million as it sold 15.56 million shares in the IPO, which priced at $27.00, compared with an expected pricing of between $24 and $26 a share, which was raised from an original expectation of between $21 and $24 a share.</p><p><blockquote>该公司隔夜表示，在IPO中出售了1556万股股票，筹集了4.2亿美元，发行价为27.00美元，而预期发行价为每股24美元至26美元，高于最初预期的每股21美元至24美元。</blockquote></p><p> <b>DICE Therapeutics</b></p><p><blockquote><b>骰子疗法</b></blockquote></p><p> DICE Therapeutics spikes 117% on its first day of trading.</p><p><blockquote>DICE Therapeutics首日交易飙升117%。</blockquote></p><p> Shares opened at $39, compared to the initial public offering price of $17 per share.</p><p><blockquote>股价开盘价为39美元，而首次公开募股价格为每股17美元。</blockquote></p><p> DICE Therapeutics, Inc., a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas, today announced the pricing of its upsized initial public offering of 12,000,000 shares of its common stock at a public offering price of $17.00 per share. All of the shares are being offered by DICE. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by DICE, are expected to be $204.0 million.</p><p><blockquote>DICE Therapeutics，Inc.是一家生物制药公司，利用其专有技术平台建立了一系列新型口服治疗候选药物，用于治疗免疫学和其他治疗领域的慢性疾病，今天宣布了其12,000，000股普通股的首次公开募股定价，公开募股价格为每股17.00美元。所有股票均由DICE发行。在扣除DICE应付的承销折扣和佣金以及其他发行费用之前，此次发行的总收益预计为2.04亿美元。</blockquote></p><p> <b>Procept Biorobotics</b></p><p><blockquote><b>Procept生物机器人</b></blockquote></p><p> Shares of Procept Biorobotics rose over 67% in their stock market debut on Wednesday.</p><p><blockquote>Procept Biorobotics的股价在周三首次上市时上涨了67%以上。</blockquote></p><p> Shares opened at $35, compared to the initial public offering price of $25 per share.</p><p><blockquote>股价开盘价为35美元，而首次公开募股价格为每股25美元。</blockquote></p><p> Redwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.</p><p><blockquote>总部位于加利福尼亚州雷德伍德城的Procept成立的目的是开发用于微创手术的先进手术机器人设备。</blockquote></p><p> Management is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.</p><p><blockquote>管理层由总裁兼首席执行官Reza Zadno博士领导，他自2020年2月以来一直在该公司工作，此前曾担任医疗保健公司Avedro的总裁兼首席执行官。</blockquote></p><p> The company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.</p><p><blockquote>该公司的第一台仪器是AquaBeam机器人系统，用于泌尿外科手术，最初的重点是治疗良性前列腺增生。</blockquote></p><p> <b>Tyra Biosciences</b></p><p><blockquote><b>泰拉生物科学公司</b></blockquote></p><p> Shares of Tyra Biosciences rose over 62% in their stock market debut on Wednesday.</p><p><blockquote>Tyra Biosciences的股价在周三首次上市时上涨了62%以上。</blockquote></p><p> Shares opened at $29.9, compared to the initial public offering price of $16 per share.</p><p><blockquote>股价开盘价为29.9美元，而首次公开募股价格为每股16美元。</blockquote></p><p> Carlsbad, California-based Tyra was founded to develop technologies that overcome tumor resistance to targeted oncology treatments such as kinase inhibitors.</p><p><blockquote>总部位于加利福尼亚州卡尔斯巴德的Tyra成立的目的是开发克服肿瘤对靶向肿瘤治疗（如激酶抑制剂）耐药性的技术。</blockquote></p><p> Management is headed by co-founder, president and CEO Todd Harris, Ph.D., who has been with the firm since inception and was previously Head of Corporate Development at Sienna Biopharmaceuticals.</p><p><blockquote>管理层由联合创始人、总裁兼首席执行官托德·哈里斯博士领导，他自公司成立以来一直在公司工作，此前曾担任Sienna Biopharmaceuticals的企业发展主管。</blockquote></p><p> The firm's lead candidate, TYRA-300, is in IND-enabling status for the treatment of muscle invasive bladder cancer, MIBC.</p><p><blockquote>该公司的主要候选药物TYRA-300处于治疗肌肉浸润性膀胱癌MIBC的IND支持状态。</blockquote></p><p></p><p> <b>EzFill</b></p><p><blockquote><b>埃兹菲尔</b></blockquote></p><p> Shares of Mobile fueling company EzFill rose over 13% in their stock market debut on Wednesday.\\</p><p><blockquote>移动加油公司EzFill的股价在周三首次上市时上涨了13%以上。\\</blockquote></p><p> Shares opened at $4.48, compared to the initial public offering price of $4 per share.</p><p><blockquote>股价开盘价为4.48美元，而首次公开募股价格为每股4美元。</blockquote></p><p> EzFill is a leading participant in the fast-growing mobile fuel industry, with the largest market share in its home state of Florida. Its mission is to disrupt the gas station fueling model by providing consumers and businesses with the convenience, safety, and touch-free benefits of on-demand fueling services brought directly to their locations. For commercial and specialty customers, at-site delivery during downtimes enables operators to begin their daily operations with fully fueled vehicles.</p><p><blockquote>EzFill是快速增长的移动燃料行业的领先参与者，在其家乡佛罗里达州拥有最大的市场份额。其使命是通过为消费者和企业提供直接带到其所在地的按需加油服务的便利、安全和免接触的优势，颠覆加油站加油模式。对于商业和专业客户，停机期间的现场交付使运营商能够使用充满燃料的车辆开始日常运营。</blockquote></p><p> The net proceeds from the initial public offering will be used to gain additional market share in Florida where it is currently the largest on-demand fuel provider, national expansion, technology development, debt restructuring, and other general corporate and working capital expenses.</p><p><blockquote>首次公开募股的净收益将用于在佛罗里达州获得额外的市场份额、全国扩张、技术开发、债务重组以及其他一般企业和营运资本支出。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO yesterday review：IPO boom comeback<blockquote>美国IPO昨日回顾：IPO热潮卷土重来</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO yesterday review：IPO boom comeback<blockquote>美国IPO昨日回顾：IPO热潮卷土重来</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-16 21:06</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week.</p><p><blockquote>在短暂的假期周经历了一波发行之后，本周有10起IPO计划筹集超过30亿美元的资金。</blockquote></p><p> There were 8 IPOs shining on Wednesday.</p><p><blockquote>周三有8只IPO大放异彩。</blockquote></p><p> <b>Thoughtworks</b></p><p><blockquote><b>Thoughtworks</b></blockquote></p><p> Shares of Thoughtworks Inc jumped nearly 40% in their Nasdaq debut on Wednesday, valuing the company at nearly $9 billion, after the software consultancy firm priced its initial public offering well above range.</p><p><blockquote>Thoughtworks Inc周三在纳斯达克首次公开募股的定价远高于区间，该公司股价上涨近40%，估值接近90亿美元。</blockquote></p><p> The company’s stock opened at $26, compared with its initial public offering price of $21. This was above its targeted price range of $18 to $20.</p><p><blockquote>该公司股票开盘价为26美元，而其首次公开募股价格为21美元。这高于其18至20美元的目标价格范围。</blockquote></p><p> Backed by Germany’s Siemens AG, Thoughtworks sold 16.4 million shares in the IPO, raising about $344 million. Other investors, including funds advised by Apax Partners, sold about 20.4 million shares.</p><p><blockquote>在德国西门子公司的支持下，Thoughtworks在IPO中出售了1640万股股票，筹集了约3.44亿美元。包括Apax Partners咨询的基金在内的其他投资者出售了约2040万股。</blockquote></p><p> The company, which helps firms digitize their operations, counts Canadian wireless carrier Telus Corp, German luxury carmaker Daimler AG, U.S. supermarket chain Kroger Co and payments company PayPal Holdings Inc as customers.</p><p><blockquote>该公司帮助企业实现运营数字化，其客户包括加拿大无线运营商Telus Corp、德国豪华汽车制造商Daimler AG、美国连锁超市Kroger Co和支付公司PayPal控股公司。</blockquote></p><p> <b>On Holding AG</b></p><p><blockquote><b>安控股股份公司</b></blockquote></p><p> Shares of Roger Federer-backed On Holding AG jumped nearly 46% in their debut on the New York Stock Exchange on Wednesday.</p><p><blockquote>周三，罗杰·费德勒(Roger Federer)支持的On Holding AG股价在纽约证券交易所首次亮相时上涨了近46%。</blockquote></p><p> The company sold 31.1 million shares in its initial public offering (IPO) priced at $24, well above its $20 to $22 target price range, raising $746.4 million. Its stock opened at $35.40.</p><p><blockquote>该公司在首次公开募股（IPO）中以24美元的价格出售了3110万股，远高于其20至22美元的目标价区间，筹集了7.464亿美元。其股票开盘价为35.40美元。</blockquote></p><p> On was founded in 2010 by running enthusiasts Olivier Bernhard, David Allemann and Caspar Coppetti, with Federer investing an undisclosed sum in the company in 2019.</p><p><blockquote>On由跑步爱好者Olivier Bernhard、David Allemann和Caspar Coppetti于2010年创立，费德勒于2019年向该公司投资了一笔未公开的金额。</blockquote></p><p> <b>Dutch Bros</b></p><p><blockquote><b>荷兰兄弟</b></blockquote></p><p> Shares of Dutch Bros Inc, which is backed by private equity firm TSG, rose over 59% in their stock market debut on Wednesday.</p><p><blockquote>由私募股权公司TSG支持的Dutch Bros Inc的股价周三在股市首次亮相时上涨了59%以上。</blockquote></p><p> Shares opened at $32.5, compared to the initial public offering price of $23 per share.</p><p><blockquote>股价开盘价为32.5美元，而首次公开募股价格为每股23美元。</blockquote></p><p> Dutch Bros was founded in 1992 by brothers Dane and Travis Boersma, third-generation dairy farmers who were forced to leave the business due to industry-wide disruption. They started experimenting with coffee beans and began selling espresso from a pushcart by the railroad tracks in Grants Pass, Oregon, which is still the company’s headquarters.</p><p><blockquote>Dutch Bros由Dane Boersma和Travis Boersma兄弟于1992年创立，他们是第三代奶农，由于全行业的混乱而被迫离开该公司。他们开始尝试咖啡豆，并开始在俄勒冈州格兰茨帕斯的铁轨旁用手推车出售浓缩咖啡，那里仍然是公司的总部。</blockquote></p><p> The coffee chain sold 21.1 million shares in its IPO on Tuesday, raising about $484 million. The IPO was priced above Dutch Bros’ earlier targeted price range of $18 per share to $20 per share.</p><p><blockquote>这家咖啡连锁店周二在IPO中出售了2110万股股票，筹集了约4.84亿美元。此次IPO定价高于荷兰兄弟此前每股18美元至20美元的目标价格区间。</blockquote></p><p> <b>Definitive Healthcare</b></p><p><blockquote><b>权威医疗保健</b></blockquote></p><p> Shares of Definitive Healthcare rose over 60% in their stock market debut on Wednesday.</p><p><blockquote>Definitive Healthcare的股价在周三首次上市时上涨了60%以上。</blockquote></p><p> Definitive Healthcare Corp Class A Shares Open At $37.25 In Nasdaq Debut Versus Ipo Price Of $27.00/Share.</p><p><blockquote>Definitive Healthcare Corp A类股票在纳斯达克首次亮相时开盘价为37.25美元，而Ipo价格为每股27.00美元。</blockquote></p><p> The company had said overnight that it raised $420.0 million as it sold 15.56 million shares in the IPO, which priced at $27.00, compared with an expected pricing of between $24 and $26 a share, which was raised from an original expectation of between $21 and $24 a share.</p><p><blockquote>该公司隔夜表示，在IPO中出售了1556万股股票，筹集了4.2亿美元，发行价为27.00美元，而预期发行价为每股24美元至26美元，高于最初预期的每股21美元至24美元。</blockquote></p><p> <b>DICE Therapeutics</b></p><p><blockquote><b>骰子疗法</b></blockquote></p><p> DICE Therapeutics spikes 117% on its first day of trading.</p><p><blockquote>DICE Therapeutics首日交易飙升117%。</blockquote></p><p> Shares opened at $39, compared to the initial public offering price of $17 per share.</p><p><blockquote>股价开盘价为39美元，而首次公开募股价格为每股17美元。</blockquote></p><p> DICE Therapeutics, Inc., a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas, today announced the pricing of its upsized initial public offering of 12,000,000 shares of its common stock at a public offering price of $17.00 per share. All of the shares are being offered by DICE. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by DICE, are expected to be $204.0 million.</p><p><blockquote>DICE Therapeutics，Inc.是一家生物制药公司，利用其专有技术平台建立了一系列新型口服治疗候选药物，用于治疗免疫学和其他治疗领域的慢性疾病，今天宣布了其12,000，000股普通股的首次公开募股定价，公开募股价格为每股17.00美元。所有股票均由DICE发行。在扣除DICE应付的承销折扣和佣金以及其他发行费用之前，此次发行的总收益预计为2.04亿美元。</blockquote></p><p> <b>Procept Biorobotics</b></p><p><blockquote><b>Procept生物机器人</b></blockquote></p><p> Shares of Procept Biorobotics rose over 67% in their stock market debut on Wednesday.</p><p><blockquote>Procept Biorobotics的股价在周三首次上市时上涨了67%以上。</blockquote></p><p> Shares opened at $35, compared to the initial public offering price of $25 per share.</p><p><blockquote>股价开盘价为35美元，而首次公开募股价格为每股25美元。</blockquote></p><p> Redwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.</p><p><blockquote>总部位于加利福尼亚州雷德伍德城的Procept成立的目的是开发用于微创手术的先进手术机器人设备。</blockquote></p><p> Management is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.</p><p><blockquote>管理层由总裁兼首席执行官Reza Zadno博士领导，他自2020年2月以来一直在该公司工作，此前曾担任医疗保健公司Avedro的总裁兼首席执行官。</blockquote></p><p> The company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.</p><p><blockquote>该公司的第一台仪器是AquaBeam机器人系统，用于泌尿外科手术，最初的重点是治疗良性前列腺增生。</blockquote></p><p> <b>Tyra Biosciences</b></p><p><blockquote><b>泰拉生物科学公司</b></blockquote></p><p> Shares of Tyra Biosciences rose over 62% in their stock market debut on Wednesday.</p><p><blockquote>Tyra Biosciences的股价在周三首次上市时上涨了62%以上。</blockquote></p><p> Shares opened at $29.9, compared to the initial public offering price of $16 per share.</p><p><blockquote>股价开盘价为29.9美元，而首次公开募股价格为每股16美元。</blockquote></p><p> Carlsbad, California-based Tyra was founded to develop technologies that overcome tumor resistance to targeted oncology treatments such as kinase inhibitors.</p><p><blockquote>总部位于加利福尼亚州卡尔斯巴德的Tyra成立的目的是开发克服肿瘤对靶向肿瘤治疗（如激酶抑制剂）耐药性的技术。</blockquote></p><p> Management is headed by co-founder, president and CEO Todd Harris, Ph.D., who has been with the firm since inception and was previously Head of Corporate Development at Sienna Biopharmaceuticals.</p><p><blockquote>管理层由联合创始人、总裁兼首席执行官托德·哈里斯博士领导，他自公司成立以来一直在公司工作，此前曾担任Sienna Biopharmaceuticals的企业发展主管。</blockquote></p><p> The firm's lead candidate, TYRA-300, is in IND-enabling status for the treatment of muscle invasive bladder cancer, MIBC.</p><p><blockquote>该公司的主要候选药物TYRA-300处于治疗肌肉浸润性膀胱癌MIBC的IND支持状态。</blockquote></p><p></p><p> <b>EzFill</b></p><p><blockquote><b>埃兹菲尔</b></blockquote></p><p> Shares of Mobile fueling company EzFill rose over 13% in their stock market debut on Wednesday.\\</p><p><blockquote>移动加油公司EzFill的股价在周三首次上市时上涨了13%以上。\\</blockquote></p><p> Shares opened at $4.48, compared to the initial public offering price of $4 per share.</p><p><blockquote>股价开盘价为4.48美元，而首次公开募股价格为每股4美元。</blockquote></p><p> EzFill is a leading participant in the fast-growing mobile fuel industry, with the largest market share in its home state of Florida. Its mission is to disrupt the gas station fueling model by providing consumers and businesses with the convenience, safety, and touch-free benefits of on-demand fueling services brought directly to their locations. For commercial and specialty customers, at-site delivery during downtimes enables operators to begin their daily operations with fully fueled vehicles.</p><p><blockquote>EzFill是快速增长的移动燃料行业的领先参与者，在其家乡佛罗里达州拥有最大的市场份额。其使命是通过为消费者和企业提供直接带到其所在地的按需加油服务的便利、安全和免接触的优势，颠覆加油站加油模式。对于商业和专业客户，停机期间的现场交付使运营商能够使用充满燃料的车辆开始日常运营。</blockquote></p><p> The net proceeds from the initial public offering will be used to gain additional market share in Florida where it is currently the largest on-demand fuel provider, national expansion, technology development, debt restructuring, and other general corporate and working capital expenses.</p><p><blockquote>首次公开募股的净收益将用于在佛罗里达州获得额外的市场份额、全国扩张、技术开发、债务重组以及其他一般企业和营运资本支出。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWKS":"Thoughtworks Holding Inc.","ONON":"On Holding AG","PRCT":"PROCEPT BioRobotics","DH":"Definitive Healthcare Corp.","TYRA":"Tyra Biosciences, Inc.","DICE":"DICE Therapeutics, Inc.","BROS":"Dutch Bros Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140671590","content_text":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week.\nThere were 8 IPOs shining on Wednesday.\nThoughtworks\nShares of Thoughtworks Inc jumped nearly 40% in their Nasdaq debut on Wednesday, valuing the company at nearly $9 billion, after the software consultancy firm priced its initial public offering well above range.\nThe company’s stock opened at $26, compared with its initial public offering price of $21. This was above its targeted price range of $18 to $20.\nBacked by Germany’s Siemens AG, Thoughtworks sold 16.4 million shares in the IPO, raising about $344 million. Other investors, including funds advised by Apax Partners, sold about 20.4 million shares.\nThe company, which helps firms digitize their operations, counts Canadian wireless carrier Telus Corp, German luxury carmaker Daimler AG, U.S. supermarket chain Kroger Co and payments company PayPal Holdings Inc as customers.\nOn Holding AG\nShares of Roger Federer-backed On Holding AG jumped nearly 46% in their debut on the New York Stock Exchange on Wednesday.\nThe company sold 31.1 million shares in its initial public offering (IPO) priced at $24, well above its $20 to $22 target price range, raising $746.4 million. Its stock opened at $35.40.\nOn was founded in 2010 by running enthusiasts Olivier Bernhard, David Allemann and Caspar Coppetti, with Federer investing an undisclosed sum in the company in 2019.\nDutch Bros\nShares of Dutch Bros Inc, which is backed by private equity firm TSG, rose over 59% in their stock market debut on Wednesday.\nShares opened at $32.5, compared to the initial public offering price of $23 per share.\nDutch Bros was founded in 1992 by brothers Dane and Travis Boersma, third-generation dairy farmers who were forced to leave the business due to industry-wide disruption. They started experimenting with coffee beans and began selling espresso from a pushcart by the railroad tracks in Grants Pass, Oregon, which is still the company’s headquarters.\nThe coffee chain sold 21.1 million shares in its IPO on Tuesday, raising about $484 million. The IPO was priced above Dutch Bros’ earlier targeted price range of $18 per share to $20 per share.\nDefinitive Healthcare\nShares of Definitive Healthcare rose over 60% in their stock market debut on Wednesday.\nDefinitive Healthcare Corp Class A Shares Open At $37.25 In Nasdaq Debut Versus Ipo Price Of $27.00/Share.\nThe company had said overnight that it raised $420.0 million as it sold 15.56 million shares in the IPO, which priced at $27.00, compared with an expected pricing of between $24 and $26 a share, which was raised from an original expectation of between $21 and $24 a share.\nDICE Therapeutics\nDICE Therapeutics spikes 117% on its first day of trading.\nShares opened at $39, compared to the initial public offering price of $17 per share.\nDICE Therapeutics, Inc., a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas, today announced the pricing of its upsized initial public offering of 12,000,000 shares of its common stock at a public offering price of $17.00 per share. All of the shares are being offered by DICE. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by DICE, are expected to be $204.0 million.\nProcept Biorobotics\nShares of Procept Biorobotics rose over 67% in their stock market debut on Wednesday.\nShares opened at $35, compared to the initial public offering price of $25 per share.\nRedwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.\nManagement is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.\nThe company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.\nTyra Biosciences\nShares of Tyra Biosciences rose over 62% in their stock market debut on Wednesday.\nShares opened at $29.9, compared to the initial public offering price of $16 per share.\nCarlsbad, California-based Tyra was founded to develop technologies that overcome tumor resistance to targeted oncology treatments such as kinase inhibitors.\nManagement is headed by co-founder, president and CEO Todd Harris, Ph.D., who has been with the firm since inception and was previously Head of Corporate Development at Sienna Biopharmaceuticals.\nThe firm's lead candidate, TYRA-300, is in IND-enabling status for the treatment of muscle invasive bladder cancer, MIBC.\nEzFill\nShares of Mobile fueling company EzFill rose over 13% in their stock market debut on Wednesday.\\\nShares opened at $4.48, compared to the initial public offering price of $4 per share.\nEzFill is a leading participant in the fast-growing mobile fuel industry, with the largest market share in its home state of Florida. Its mission is to disrupt the gas station fueling model by providing consumers and businesses with the convenience, safety, and touch-free benefits of on-demand fueling services brought directly to their locations. For commercial and specialty customers, at-site delivery during downtimes enables operators to begin their daily operations with fully fueled vehicles.\nThe net proceeds from the initial public offering will be used to gain additional market share in Florida where it is currently the largest on-demand fuel provider, national expansion, technology development, debt restructuring, and other general corporate and working capital expenses.","news_type":1,"symbols_score_info":{"DH":0.9,"DICE":0.9,"BROS":0.9,"TWKS":0.9,"TYRA":0.9,"EZFL":0.9,"ONON":0.9,"PRCT":0.9}},"isVote":1,"tweetType":1,"viewCount":689,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/885284410"}
精彩评论